Biotechnology, an industry with potential, but little financing

The accelerator, details Anabalón, has a support program for companies to raise capital, carry out internationalization processes and have relationships with investors to remove obstacles and make the path freer and faster.

Biotechnology in Latin America begins to grow

In September, this company closed a capital raise for 1.5 million dollars to continue investing in biotech startups, helping them grow and even reach other territories,

So far they already have 28 startups in their portfolio. 50% are from Chile and the rest from other Latin American countries, mainly Argentina and Colombia. In Mexico, the accelerator invested in a healtech called Bleps Vision, whose proposal is to monitor the cornea to identify possible deformations.

Although it could be said that there is a lag for the industry in Latin America, the specialist qualifies by saying that “painting everything the same color would be irresponsible, rather we should see it by sector”: He also highlights that it is more relevant to see the potential of the region both in population as well as in the market for these technologies, although he accepts that salaries are low compared to other areas.

“We have very good science in the region and it has a fertile place to test it. Latam’s potential in scientific, demographic and regulatory terms is great, but the capital intensity that the United States has, for example, is lacking and the payment capacity that exists in those markets is lacking”, he concludes.